
2.39BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US92346J1088
CUSIP
00253U107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
108.42
PEG Ratio
-
Book Value
6.98
Dividend Share
-
Dividend Yield
-
Earnings Share
0.43
Wall Street Target Price
57.14
EPS Estimate Current Year
0.45
EPS Estimate Next Year
0.85
EPS Estimate Current Quarter
-0.1567
EPS Estimate Next Quarter
0.015
Most Recent Quarter
-
Revenue TTM
292,086,016
Gross Profit TTM
218,592,000
EBITDA
27,897,000
Profit Margin
7.35%
Return On Assets TTM
2.17%
Return On Equity TTM
6.59%
Revenue Per Share TTM
5.777
Qtly Revenue Growth YOY
30.10%
Diluted Eps TTM
0.43
Qtly Earnings Growth YOY
18.90%
Trailing PE
108.42
Forward PE
98
Price Sales TTM
8.151
Price Book MRQ
6.6912
Enterprise Value Revenue
7
Enterprise Value EBITDA
66
760.00
3.03%22.75
2.52%865.00
0.00%88.94
0.00%124.85
-12.62%259.59
-12.18%853.82
-2.26%187.48
-2.14%476.99
-0.98%204.11
-0.83%